Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Long-Lived, Nonenzymatic Signal Generation Chemiluminescence Immunoassay for Pretreatment-Free Detection of Lincomycin in Milk.

Created on 27 Jul 2026

Authors

Zhenyuan Chen, Mengyao Wang, Weicheng Lin, Zhenlin Xu, Hongtao Lei, Sheng Chen, Xiangmei Li

Published in

Analytical chemistry. Jul 27, 2026. Epub Jul 27, 2026.

Abstract

To address the technical limitations of the short chemiluminescence (CL) lifetime and poor stability of chemiluminescence emission in conventional CL systems, a novel CL with prolonged lifetime and high intensity with nonenzymatic signal generation was innovatively developed. Deep red carbon dots (DRCDs) served as efficient energy acceptors, while bis(2,4,6-trichlorophenyl) oxalate (TCPO)-H2O2 acted as energy donors. Compared with traditional systems, the luminescence lifetime was extended by 2 orders of magnitude, accompanied by an excellent CL quantum yield of 6.99 × 10-3 einsteins/mol. Based on this, a TCPO-H2O2-DRCDs-based CL immunoassay was first developed for lincomycin detection in milk. The method achieved a detection limit as low as 0.025 ng/mL, demonstrating a 39.2-fold improvement in sensitivity over reported methods. Benefiting from the nonenzymatic signal emission mechanism and long-lived glow-type signal output, the assay exhibited significantly enhanced stability and allowed quantitative analysis without relying on expensive, large-scale transient signal detection equipment. Moreover, samples could be analyzed without any pretreatment, greatly improving analytical throughput and operational convenience. Results from 10 real samples showed high consistency with confirmatory LC-MS/MS data (R2 > 0.99). The constructed stable signal-output, long-lived CL signaling platform lays a solid theoretical and technical foundation for the development of next-generation highly sensitive and robust immunoassays suitable for point-of-care testing and resource-limited settings.

PMID:
42504614
Bibliographic data and abstract were imported from PubMed on 27 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement